Placeholder canvas
HomeBusinessWegovy, the popular weight-loss drug, in high demand like 'Viagra

Wegovy, the popular weight-loss drug, in high demand like ‘Viagra

Published on

There is a recent buzz about the new drug Wegovy that has been making waves on social media and garnering attention from celebrities like Elon Musk. The drug, which has been touted as a weight-loss wonder, has led to a significant transformation for people like Casper Nielsen, who has shed an impressive 60kg over the past two years. Fuelled by the drug’s success, its manufacturer, Danish drug-maker Novo Nordisk, has become Europe’s most valuable listed company. The drug’s active ingredient, semaglutide, has shown promising results in not only controlling blood sugar but also aiding in significant weight loss.

Wegovy’s popularity has led to soaring sales, with the drug now available in several countries, and is being prescribed by the NHS in the UK. Its success has driven Novo Nordisk’s net profit to increase by 51%, leading to a significant impact on the Danish economy, which has experienced growth largely due to the pharmaceutical industry. However, the popularity of the drug has raised questions about affordability and access, with some patients unable to afford it and medical insurance providers reluctant to cover it due to its high price and rising patient numbers.

Despite these concerns, the success of Wegovy has sparked an arms race in the weight-loss drugs market, with Novo Nordisk’s chief financial officer predicting continued strong sales and growth of the drug in 2024. As the drug is transforming lives, it has raised important questions about the inequality in health, affordability, and the weight-loss solution for an increasingly overweight population.

Source link

Latest articles

Three games exiting Xbox Game Pass in early March 2024.

Microsoft has announced that three games will be leaving Xbox Game Pass in early...

‘Rust’ armorer accused of mishandling guns and facing emotional testimony in trial.

The first week of Hannah Gutierrez-Reed’s criminal trial focused on the eyewitness accounts of...

Shiba Inu (SHIB) Price Smashes Long-Term Resistance: What’s Next?

After 560 days of being stuck under a descending resistance trend line, the Shiba...

3 AI stocks that could boost your wealth

Warren Buffett's wisdom highlights the power of a few key winners in the world...

More like this

Three games exiting Xbox Game Pass in early March 2024.

Microsoft has announced that three games will be leaving Xbox Game Pass in early...

‘Rust’ armorer accused of mishandling guns and facing emotional testimony in trial.

The first week of Hannah Gutierrez-Reed’s criminal trial focused on the eyewitness accounts of...

Shiba Inu (SHIB) Price Smashes Long-Term Resistance: What’s Next?

After 560 days of being stuck under a descending resistance trend line, the Shiba...